UnitedHealth Launches Bundled Payment Program at MD Anderson
The pilot, which will has been launched for head and neck cancer patients, will include quality measures to ensure adequate patient care.
Monitoring Drug Safety in the Age of Big Data
Healthcare databases may allow for greater access to real-world medical data, but they can become a risk to patients and healthcare systems if they are not considered carefully, according to a study published in Current Epidemiology Reports.
Residency Has Lasting Effect on Spending Habits of Doctors
Researchers found that physicians who trained in a part of the country with higher healthcare expenditures will continue to practice that type of medicine even if they move to a region with lower spending habits.
Oncotype DX DCIS Can Predict Recurrence in Women With DCIS
Based on results presented at the ongoing San Antonio Breast Cancer Symposium, the gene panel was found to predict the risk of disease recurrence in women who had undergone breast conservation surgery for DCIS.
Cyramza Receives Extended Approval for Advanced NSCLC
The combination of (Cyramza) ramucirumab with docetaxel was today approved by the FDA for the treatment of advanced non-small cell lung cancer and in those who have been treated with platinum-based therapy.
Nashville Star Charles Esten Shares Personal Experience in Battling Rare Blood Disease
Actor and singer Charles Esten, whose daughter was diagnosed with leukemia when she was 2-and-a-half, shares the challenging and painful experiences of battling the disease.
A Provider Navigates the Reimbursement Journey
Fred Pelzman, MD, shares his woes as he navigates the "growing demands" of insurance companies to make care more patient-centric.
One For Choosing Wisely in Breast Cancer
A study presented at the San Antonio Breast Cancer Symposium showed that Herceptin may not complement chemotherapy in breast tumors with a high level of immune infiltration.
A Physician Examines Clinical Pathways
Stick to pathways or use them as guidance? A physician explores.
Hopkins Adapts to Prevent Cancer Risk of Uterine Morcellation
Just prior to the FDA guidance on the use of power morcellators, Johns Hopkins made public a new care plan for managing fibroids or hysterectomies in women over age 50 years.
Influence of Socioeconomic Status, Race on 30-Day Readmission Rates
A new report has validated concerns that CMS readmission penalty models do not factor in socioeconomic and race factors and therefore unfairly penalize hospitals caring for low-income, uninsured, and vulnerable populations.
Slow Adoption of Less Costly, Patient-Preferred Radiation Therapy
A majority of breast cancer patients in the US are receiving longer radiation therapy than is necessary and compared with their counterparts in other countries, according to a new study published in JAMA.
Making a Case for Biomarkers in Cancer Immunotherapy
Immune response boosters in oncology, approved for melanoma so far, are being evaluated in several different cancer types. While the drugs perform well, there is a definite need to identify responsive patient cohorts.
Aetna Foundation Issues $4.5 Million Challenge to Accelerate Digital Health Innovation
The Aetna Foundation announced the Healthier World Innovation Challenge, a $4.5 million initiative designed to steer digital health innovation to improve chronic health outcomes in underserved communities.
Merck's Ebola Vaccine Trial Halted
Reuters has reported that Merck's Ebola vaccine trial has been temporarily halted.
Gardasil 9 Approved for 5 Additional HPV Types
With this approval, the vaccine can effectively protect against 5 additional types of HPV than the parent Gardasil vaccine, thereby preventing the development of cervical, vulvar and vaginal cancers, based on a randomized clinical trial.
How Should E-Cigarettes Be Regulated?
Should e-cigarettes be regulated he same way as cigarettes? Should marketing and sales restrictions be the same? Policy and health experts chime-in.
States Offer Poor Access for Medicaid Managed Care Networks, OIG Report Finds
As Medicaid enrollment grows under the program's expansion, there are not enough providers to serve the increased amounts of enrollees, according to a new report from the Office of the Inspector General that measured the availability of specific providers in Medicaid managed care networks.
Need to Establish National Healthcare Standards for Children, Study Suggests
The study published in Health Affairs recommends standardization of benefit plans across states for children, especially those related to developmental abilities.
Study: Doctors Paid More for Multiple Procedures Than for Multiple Patients
Highly-paid doctors make more money ordering multiple procedures for individual patients than they earn seeing multiple patients, suggesting payment reform under the Affordable Care Act has yet to be realized.
$36.3 Million Awarded to Reward Health Center Quality Improvements
Health centers across the country will receive $36.3 million in Affordable Care Act funding to invest in ongoing quality improvement activities, HHS announced on Tuesday.
After Astra, Pfizer Taps Other Immuno-Oncology Markets
With the immuno-oncology field getting more intense, Pfizer continues its struggle to gain a foothold in the field. Following unsuccessful attempts to bid for AstraZeneca, Pfizer has now signed a deal with a Belgian company, iTeos Therapeutics.
Immuno-Oncology Getting Closer to Being Personalized: Nature Study
The Nature letter published results showing that the monoclonal antibody targeting PD-1 had antitumor activity, but more importantly, the response was greater in patients overexpressing the PD-L1 receptor, thereby opening the doors for targeted therapy.
Americans Dread Health Insurance Shopping Despite Exchange Improvement
The federal government may have made strides to improve the health insurance exchanges since last year’s open enrollment, but a majority of Americans view shopping for health insurance as just as bad as or worse than doing their taxes.
New Stroke Care Delivery Model Reduces Disability, Costs
A new stroke care delivery model developed by researchers at the Stanford Clinical Excellence Research Center could lower US healthcare costs by as much as $1.6 billion per year, according to a study published in Stroke.